Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: 5 | History Defined

A whale with a lot of money to spend has taken a noticeably bullish stance on Medtronic. Looking at options history for Medtronic (NYSE:MDT) we detected 10 strange trades.

Benzinga

Check Out What Whales Are Doing With MDT

A whale with a lot of money to spend has taken a noticeably bearish stance on Medtronic. Looking at options history for Medtronic (NYSE:MDT) we detected 17 strange trades.

Benzinga

Is It Too Late to Get in on This Warren Buffett Stock?

Renowned kidney dialysis provider DaVita (DVA) reported solid second-quarter results. The company is expected to witness massive growth in the coming quarters, backed by strength in DaVita Kidney Care and steady expansion in international markets. Moreover, Warren Buffett’s Berkshire holds nearly 38% stake in the company. However, is it too…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Medtronic Stock Keeps Ticking Forward

Medical device maker Medtronic (NYSE: MDT) stock is trading down (-14%) for the year. Medtronic is the world's largest medical device maker with a portfolio of glucose monitors, stents, insulin pumps, pacemakers, and catheters. It serves patients in over 150 countries.

Benzinga

Now is a Great Time to Pick Up This Passive Income Stock

The surging inflation and the Fed’s efforts to tame it by aggressively hiking interest rates have led to many analysts forecasting a recession later this year. Investors must consider picking up stocks that generate passive income in an uncertain economic environment. Medtronic (MDT) recently announced an 8% increase in its…

StockNews.com

Check Out What Whales Are Doing With MDT

Someone with a lot of money to spend has taken a bullish stance on Medtronic (NYSE:MDT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

6 Stocks To Buy That Are Near 52-Week Lows

Weakness in the S&P 500 has made life unpleasant for investors so far in 2022, but it has also created buying opportunities in a handful of high-quality stocks. Long-term investors looking to buy the dip can find plenty of stocks to buy that are at or near their lowest prices…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

5 All-Weather Stocks to Protect Your Portfolio from a Bear Market

In the current, uncertain market environment, one of the best strategies to protect one’s portfolio is to invest in stocks capable of withstanding all market and economic conditions. With fears of a looming recession, we think investors could look to add the stocks of all-weather companies Constellation Brands (STZ), Johnson…

StockNews.com

Medtronic, DaVita To Jointly Form Kidney Health-Focused Company

Medtronic plc (NYSE:MDT) and DaVita Inc (NYSE:DVA) intend to form a new, independent kidney care-focused medical device company (NewCo). NewCo will focus on developing a broad suite of novel kidney care products and solutions, including future home-based products. Medtronic and DaVita will co-own the NewCo, each with equal equity stakes and led by an…

Benzinga

Why Medtronic Shares Are Plunging Today?

Medtronic Plc's (NYSE:MDT) Q4 FY22 sales of $8.09 billion decreased 1% Y/Y on a reported basis but increased 1% organically, missing the consensus of $8.42 billion. The company has forecasted Q4 organic revenue growth of approximately 5.5%. Q4 adjusted EPS of $1.52 increased 2%, missing the analyst consensus of $1.56. Medtronic's heart device…

Benzinga

Medtronic: Q4 Earnings Insights

Medtronic (NYSE:MDT) reported its Q4 earnings results on Thursday, May 26, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga

Are Medical Device Stocks Good Investments During a Recession?

The stock market has witnessed a massive sell-off lately on concerns over the Fed’s aggressive interest rate hikes to fight the decade-high inflation. Many analysts expect the economy to slip into recession due to the Fed’s monetary policy tightening. Since the medical device industry is known to be one of…

StockNews.com

2 Wide-Moat Stocks to Add to Your Portfolio Right Now

The major stock market indexes surged yesterday after the Fed Reserve raised benchmark interest rates by half a percentage point. However, the stock market is expected to remain under pressure at least in the near term on continuing macroeconomic and geopolitical concerns. So, we think it could be wise to…

StockNews.com

Medtronic vs. Edwards Lifesciences: Which Medical Device Stock is a Better Buy?

Growing demand from an aging population to track their diseases and increased focus on critical surgical procedures with lesser COVID-19 pressures on hospitals make the medical devices industry’s prospects bright. Moreover, the integration of emerging technologies and continued innovations should drive the industry’s growth. Therefore, prominent players in this space,…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Medtronic Recalls Harmony Delivery Catheter Due Risk Of Breaking While Procedure

Medtronic Plc (NYSE:MDT) is recalling the Harmony Delivery Catheter, part of the Transcatheter Pulmonary Valve (TPV), due to the possibility that the bond holding the capsule at the end of the delivery catheter may break during a procedure. Harmony TPV System is used to treat a leaky native or surgically repaired right…

StockNews.com

Intuitive Surgical vs. Medtronic: Which Medical Device Stock is a Better Buy?

Increased focus on elective surgeries and growing demand from the aging population have been helping medical device companies to grow their revenues. Moreover, continuous innovations and the integration of advanced technologies position the industry well for growth. Therefore, prominent players in this space, Intuitive Surgical (ISRG) and Medtronic (MDT), should…

Benzinga

Medtronic's Portfolio Management Unlikely To Be A 'Magic Bullet,' Says Needham

Needham published a report that pointed to previous comments from Medtronic plc's (NYSE: MDT) management that indicate the potential for changes in the coming year, with a spinoff of a large business considered an option.

StockNews.com

Dividend Investors: 5 Stocks to Shore Up Your Portfolio

Amid the current market fluctuations owing to continuing geopolitical tensions, soaring oil prices, a rising interest rate environment, and supply chain disruptions, it could be wise to add quality dividend stocks Medtronic (MDT), Sanofi (SNY), Nippon Telegraph, and Telephone (NTTYY), Honda Motor (HMC) and Hewlett Packard (HPE) to one’s portfolio…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Wide-Moat Stocks That Look Cheap: Biogen, Medtronic, and Bristol-Myers Squibb

: Major stock indices appear heading for weekly gains with the Fed’s first interest rate hike digested easily by investors. However, the market is expected to remain under pressure in the near term. So, because wide-moat companies generally do well in these market conditions, we think cheap wide-moat stocks Bristol-Myers…

Benzinga

Medtronic's US Trial Of GI Genius Endoscopy Module Reduces Missed Colorectal Polyps By 50%

Medtronic plc (NYSE:MDT) announced final findings from a study that confirmed the effectiveness of the GI Genius intelligent endoscopy module. GI Genius uses AI to aid in detecting colorectal polyps during colonoscopy, potentially helping to prevent colorectal cancer (CRC). The study published in Gastroenterology found that the use of GI Genius in conjunction with…

Benzinga

Medtronic's Q3 Profit In Line With Expectation Despite COVID-19 Impact On Procedure Volume

Medtronic Plc's (NYSE: MDT) Q3 FY22 sales of $7.76

Benzinga

Recap: Medtronic Q3 Earnings

Medtronic (NYSE:MDT) reported its Q3 earnings results on Tuesday, February 22, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga

Expert Ratings For Medtronic

Within the last quarter, Medtronic (NYSE:MDT) has observed the following analyst ratings:

Benzinga

What 20 Analyst Ratings Have To Say About Medtronic

Medtronic (NYSE:MDT) has observed the following analyst ratings within the last quarter:

Benzinga

Where Medtronic Stands With Analysts

Medtronic (NYSE:MDT) has observed the following analyst ratings within the last quarter:

1 … 3 4 5 6

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

595 stories

James Ellis

13 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.